Nachrichten zur Pfizer Inc. Aktie

Why Im Avoiding 6%-Yielding Pfizer Stock

…

Targinta’s CEO to BioStock: “Strong interest in ADCs in 2023”

During 2023, we have witnessed several significant business deals involving Antibody-drug conjugates (ADC), both in preclinical and clinical phase. This…

Is Pfizer Stock a Buy Near 10-Year Lows for Its 6% Dividend Yield?

Pfizer stock is fresh off the lowest price levels shareholders have seen in a decade. Why is PFE stock so…

Better Bull Market Buy: Pfizer vs. Moderna

…

Better Bull Market Buy: Pfizer vs. Moderna

There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks.…

Aktienmarkt: Kurs der Pfizer-Aktie im Plus (25,9775 €)

Der Anteilsschein von Pfizer notiert heute ein wenig fester. Das Papier kostete zuletzt 28,29 US-Dollar. Am US-amerikanischen Aktienmarkt hat sich…

Pfizer Insider Convicted in High-Stakes Covid Pill Trading Scandal By Quiver Quantitative

Pfizer Insider Convicted in High-Stakes Covid Pill Trading Scandal…

Ex-Pfizer Employee Convicted of Insider Trading on Covid Pill

A former Pfizer Inc. employee was convicted of using confidential information about the company’s Covid-19 treatment to make illegal options…

Pfizer: CEO Bets His Pension On The Stock - Upgrading To Buy

…

Zinswende beflügelt BioTech! Bayer, Pfizer, FendX, Evotec und MorphoSys auf dem fundamentalen Prüfstand

Der BioTech-Sektor - Der Auftakt lässt noch zu wünschen übrig Der Jahresstart im Sektor Biotechnologie konnte bislang nicht begeistern. Seitwärts…

The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space

Wall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss…

Top 5 Life Science ETFs

Taking a position in a life science exchange-traded fund (ETF) provides exposure to a basket of stocks focused on the…

Why one strategist believes Pfizer and two other stocks are buys

David Dietze, senior investment strategist of Peapack Private Wealth Management, tells Quartz why Pfizer, Exxon, and Walgreens could be great…

Pfizer’s Bourla Bets His Pension on Company Stock as CEO Defends Drug Firm

…

Antiemetics Drugs Market Size Projected to Surge USD 5.4 Billion Growth by 2032, Exhibit a CAGR of 5.9%

Antiemetics drugs market size from USD 3.1 billion in 2022 to USD 5.4 billion in 10 years. The rising prevalence…

Im Passing on Pfizer Stock in 2024. Heres Why.

…

Im Passing on Pfizer Stock in 2024. Heres Why.

Pfizers best days might be behind it as demand for its COVID-19 products hits a wall.…

[Latest] Global Bone and Joint Health Supplement Market Size/Share Worth USD 17.17 Billion by 2032 at a 9.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

2 Red Flags That Could Sink Pfizer in 2024

Pfizer shares dropped more than 40% last year.…

Pfizer Is Part Of The 2024 Healthcare Sector Rally Cohort

…

Global $67B+ Womens Health Market Landscape 2024-2030: Analysis by Age, Application and Region

Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Womens Health Market Size, Share & Trends Analysis Report…

AstraZeneca: Rebound in 2024 With Double-Digit Earnings Growth

Stocks Analysis by MarketBeat.com (Kate Stalter) covering: Eli Lilly and Company, Merck & Company Inc, Pfizer Inc, Bristol-Myers Squibb Company.…

2 Low-Priced Gene Therapy Stocks to Speculate On

Stocks Analysis by MarketBeat.com (Jea Yu) covering: Novartis AG, Vertex Pharmaceuticals Inc, Biogen Inc, Pfizer Inc. Read MarketBeat.com (Jea Yu)s…

Biontech legt Fokus auf Krebsgeschäft - Erste Mittel sollen 2026 auf den Markt

Frankfurt (Reuters) - Nach dem Ende des Corona-Booms setzt Biontech in den kommenden Jahren verstärkt auf seine Krebsforschung.

"Aktuell laufen…

Pfizer, Genmab cancer therapy under FDA priority review for full approval

…

Will Pfizers Stock Bounce Back in 2024?

The stock looks cheap, but it does come with risks.…

Will Pfizers Stock Bounce Back in 2024? @themotleyfool #stocks $PFE

The stock looks cheap, but it does come with risks.…

Bile Duct Cancer Treatment Market Trends and Forecast 2031 - Market Set for Significant Growth by 2031 Amid Rising Incidences and Technological Advancements

Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Bile Duct Cancer Treatment Market - Global Industry Analysis, Size,…

Pfizer Inc. (PFE) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)

…

Bear of the Day: Pfizer (PFE)

Negative earnings estimate revisions from analysts and weakening sales post-pandemic paint a challenging picture for the companys shares in the…

Opening Bell: Boeing-Aktie belastet Dow Jones; Bitcoin, Coinbase, Unitedhealth, Boeing, Pfizer, Nvidia, Enphase im Fokus

An den US-Börsen zeichnet sich ein uneinheitlicher Wochenauftakt ab. Der Dow Jones startet rund 120 Punkte niedriger in den Handelstag,…

Pfizer: 50% Down From The Highs, Generous Dividend, And Robust Balance Sheet

…

Pfizer: Paying Too Much To Boost Revenues

…

Pfizer: TD Cowen stuft die Aktie herab - Aktienanalyse

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von TD Cowen: Die Analysten von TD Cowen stufen die Aktie von Pfizer Inc. (ISIN: US7170811035,…

Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen By Investing.com

Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen…

Global Pharmaceuticals Market Analysis and Forecast to 2027, with Company Profiles of Key Market Players Bayer, Novartis ,Pfizer and Johnson & Johnson

Dublin, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027"…

Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge? @themotleyfool #stocks $PFE

COVID-19 products Comirnaty and Paxlovid are no longer Pfizers crown jewels. But thats OK.…

dpa-AFX ProFeed